| Date | Time | Source | Headline | Symbol | Company |
| 07/02/2024 | 11:19AM | iHub Newswire | FeaturedBNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth | | |
| 11/22/2004 | 4:10PM | PR Newswire (US) | Gedeon Richter and Forest Laboratories Announce Collaboration Agreement on Atypical Antipsychotic for Schizophrenia, Bipolar Man | NYSE:FRX | Forest Road Acquisition Corp |
| 11/15/2004 | 8:10AM | PR Newswire (US) | FDA Accepts Supplemental New Drug Application Filing to Expand Namenda's(R) Indication to Include Treatment of Mild Alzheimer's | NYSE:FRX | Forest Road Acquisition Corp |
| 11/02/2004 | 8:00AM | PR Newswire (US) | Forest Laboratories Updates Lercanidipine Development | NYSE:FRX | Forest Road Acquisition Corp |
| 11/01/2004 | 4:17PM | PR Newswire (US) | Forest Laboratories Revises FY2005 Earnings Guidance | NYSE:FRX | Forest Road Acquisition Corp |
| 10/19/2004 | 10:35AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for EMC, IBM, MCD, FRX, and MO | NYSE:FRX | Forest Road Acquisition Corp |
| 10/18/2004 | 9:07AM | PR Newswire (US) | Forest Laboratories Reports Earnings Per Share of $.79 for 2Q'05; Offers Updated Fiscal 2005 EPS Guidance | NYSE:FRX | Forest Road Acquisition Corp |
| 10/12/2004 | 5:15PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2005 Second Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 10/04/2004 | 5:30PM | PR Newswire (US) | Forest Laboratories to Exceed Fiscal 2005 Second and Third Quarter Mean Earnings Per Share Estimates | NYSE:FRX | Forest Road Acquisition Corp |
| 09/27/2004 | 9:50AM | PR Newswire (US) | Forest Laboratories Appoints Francis Perier as Senior Vice President - Finance and Chief Financial Officer | NYSE:FRX | Forest Road Acquisition Corp |
| 09/23/2004 | 9:00AM | PR Newswire (US) | Glenmark Pharmaceuticals and Forest Laboratories Announce Collaboration Agreement on PDE4 Inhibitor for Asthma and COPD | NYSE:FRX | Forest Road Acquisition Corp |
| 09/08/2004 | 3:10PM | PR Newswire (US) | /C O R R E C T I O N -- Forest Laboratories, Inc./ | NYSE:FRX | Forest Road Acquisition Corp |
| 09/07/2004 | 6:41PM | PR Newswire (US) | Forest Laboratories Announces Adoption of On-line Registry for Clinical Studies; Attorney General Agrees to Close Inquiry | NYSE:FRX | Forest Road Acquisition Corp |
| 09/02/2004 | 10:17AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for C, ERTS, COCO, FRX, and SWIR | NYSE:FRX | Forest Road Acquisition Corp |
| 08/31/2004 | 5:11PM | PR Newswire (US) | Forest Announces That Neramexane Did Not Demonstrate Statistical Significance in Recently Completed Phase III Trial in Patients | NYSE:FRX | Forest Road Acquisition Corp |
| 08/26/2004 | 9:55AM | PR Newswire (US) | Forest Laboratories Submits Response for Lexapro(R) for Panic Disorder | NYSE:FRX | Forest Road Acquisition Corp |
| 08/04/2004 | 5:30PM | PR Newswire (US) | ThinkEquity Partners LLC Transitions in Specialty Pharma Research Coverage | NYSE:FRX | Forest Road Acquisition Corp |
| 07/29/2004 | 8:20PM | PR Newswire (US) | FDA Approves Campral(R) (Acamprosate Calcium) Delayed-Release Tablets for the Treatment of Alcohol Dependence | NYSE:FRX | Forest Road Acquisition Corp |
| 07/20/2004 | 10:29AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for TASR, DAL, MAT, USB, and FRX | NYSE:FRX | Forest Road Acquisition Corp |
| 07/20/2004 | 9:02AM | PR Newswire (US) | Forest Laboratories, Inc. Announces Share Repurchase Program | NYSE:FRX | Forest Road Acquisition Corp |
| 07/20/2004 | 9:02AM | PR Newswire (US) | Forest Laboratories Reports Fiscal First Quarter Earnings of $.60 Per Share | NYSE:FRX | Forest Road Acquisition Corp |
| 07/13/2004 | 12:38PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2005 First Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 07/06/2004 | 9:04AM | PR Newswire (US) | Forest Laboratories, Inc. and PAION GmbH Announce Development and Marketing Agreement for Desmoteplase - Novel Investigational T | NYSE:FRX | Forest Road Acquisition Corp |
| 06/29/2004 | 5:46PM | PR Newswire (US) | Forest Announces Request for Information From New York State Office of the Attorney General | NYSE:FRX | Forest Road Acquisition Corp |
| 06/25/2004 | 10:11AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for TXN, RAD, MYL, FRX, and GILD | NYSE:FRX | Forest Road Acquisition Corp |
| 06/24/2004 | 5:12PM | PR Newswire (US) | Forest Discusses Disclosure of Citalopram Clinical Trial Data in Children and Adolescents | NYSE:FRX | Forest Road Acquisition Corp |
| 06/24/2004 | 5:11PM | PR Newswire (US) | Forest Announces Results of Recently Completed Lexapro(R) Pediatric Depression Clinical Trial | NYSE:FRX | Forest Road Acquisition Corp |
| 05/24/2004 | 10:44AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for GE, MVL, FRX, WYE, and ONE | NYSE:FRX | Forest Road Acquisition Corp |
| 05/06/2004 | 7:39PM | PR Newswire (US) | Depressed Patients Showed Improvement with Lexapro(TM) After Failure with Initial SSRI Treatment | NYSE:FRX | Forest Road Acquisition Corp |
| 05/06/2004 | 6:21PM | PR Newswire (US) | Namenda(TM) (memantine HCl) Provides Functional and Behavioral Benefits in Patients with Moderate to Severe Alzheimer's Disease | NYSE:FRX | Forest Road Acquisition Corp |